For new followers (and with apologies to long standing followers), I am a long established paid consultant to Oxford Nanopore - a DNA and RNA sequencing company with a very different sequencing chemistry from previous chemistries. Some background:
I've consulted for ONT for over 10 years now (!) and seen the twists and turns of both technology development and commercialisation in a complex environment. There have been some serious twists and complications.
Like a lot of successful technologies, many people need to be credited with its success - original academics (David Deamer, Dan Branton, George Church, Hagen Bayley ...), the business people who saw the opportunity (Gordon Sanghera, Spike Willcoxs)+ scientists inside ONT >>
I know the scientists inside ONT the best - Clive Brown (@The__Taybor), James Clarke, Rosemary Dokos, Stuart Reid, Tim Massingham, Chris Seymour and others and there is huge amount of simply awesome science *inside* the development/company process.
A good example is that much of the smarts of the device is not about the nanopore, it is about the lipid bilayer and the device which holds it. As Clive wryly points out "we're shipping soap bubbles around the world and they have to work at the other end"
Then there is massive drama about the motor. Nanopores in the 1990s was famously "the sequencing technology for the future, and always will be" because of trying to control the movement of nucleic acid through the pore.
There is a whole sideshow of silicon meets biological materials and just how fiddly a device which can measure current through a single molecule is to all sorts of little differences (buffers, robustness, QC...)
Finally decoding the signal is ... quite a drama (as Chris or Tim will point out). It is not a simple signal, and although explicit, generative models (HMMs and friends) are good, Deep Neural Networks have been key in leveraging the signal
(not least because one has both amplitude and time-domain signal, convoluted across multiple base pairs and in some case spanning the motor position some 16 base pairs away).
...but... then... you get something that sequence DNA or RNA, with the length of read only limited by sample prep (yup, you read that right, there is no *inherent* limitation to the length of nucleic acid polymer through a nanopore) on a set up which is the size of a stapler.
It can read DNA or RNA; it senses DNA and RNA modifications "as if they are a new base" (cue - huge training and informatics headaches, but a nice headache to have - suddenly the RNA modification world is accessible to us)
It is fast (first reads off in 30mins), asynchronous and very portable. People have sequenced in space (ISS) (!!!), in Antartica, in Costa Rica jungles; sequencing in GPs practice should be ok :)
What's not to like? Well... skeptics will point at error rates, which have been steadily dropping with better pores (R10.3 better than R9 series), better movement control in buffering etc and better informatics; yet more improvements are coming down the pipe
Although there is just one molecule of DNA going through the pore there are many ions traversing in each time-slice of sensing so there is not a stochastic sensing problem; there is a single molecule modification/state/conformation issue which is a blessing+curse
Quite where the final single molecule limit is I don't know - but it has a way to go. But then as soon as one gets into consensus building in a variety of ways (double strands, UMIs, assembly haplotypes...) the situation is really sorted. Plenty plenty more headroom.
I've really enjoyed hanging out and helping out where I can the nanopore crew (Doffs hat), and it has also inspired some new science from my group / associated with me.
My two current favourites are RNA modification detection (With Tommaso Leonardi and Adrien Leger, biorxiv.org/content/10.110…) and Adaptive sampling with Nick Goldman and Matt Loose groups (biorxiv.org/content/10.110…)

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Ewan Birney

Ewan Birney Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @ewanbirney

23 Feb
In the rush of all the announcements yesterday from the UK, it might be easy to miss this Public Health Scotland / Usher institute preprint on real world effectiveness of both the Ox/Az + BioNTech/Pfzier vaccine (Note: I am still on the trial for Ox/Az). ed.ac.uk/files/atoms/fi…
The most important thing is that they both work - really very well (age adjusted odds ratios getting down to 0.25 ish). If anything the Ox/Az is shading better to the Pfzier one but remember in a real world setting one doesn't have randomisation to help isolate the effect >>
This is clear evidence that both vaccines work - which we knew from trials, and for BioNTech/Pfzier real world Israel data; it shows also that effect works at the highest age ranges (for both vaccines) which was always expected but had thinner trial data in Ox/Az.
Read 7 tweets
23 Feb
Doing a postdoc in computational biology? Got your own ideas? Want to set up your own group, with freedom to follow your vision? Apply to being a Group Leader (PI position) @emblebi embl.org/jobs/position/…
EMBL-EBI is part of the international treaty organisation @embl; Headquartered in Heidelberg Germany, @emblebi is the UK site of @embl focused on computational biology both in blue skies research and computational data services.
The amazing and supportive John Marioni (@MarioniLab) is Head of Research @emblebi and I know he his happy to talk through any details of this position with interested candidates. We can hire from anywhere in the world, and interested in scientific potential above all.
Read 7 tweets
21 Feb
Views this afternoon in the early spring in London; crocuses are coming out, some early daffodils, and coronavirus is falling, but we're not out of this pandemic yet, and even "out" is a complex endpoint.
Context: I am an expert in human genetics and computational biology; I know experts in infectious epidemiology, viral genomics, immunology, testing and clinical trials. COI: I am long established consultant to Oxford Nanopore and I am on the Ox/Az vaccine trial as a participant.
I will comment mainly from the perspective of UK and broadly Europe which are the places I know and understand the best.
Read 34 tweets
9 Feb
The @uk_biobank is ... amazing and is basically, in my view, rebooting the science of human physiology.
Why? First it is just a really well phenotyped cohort at scale. Back in the early 2000s a number of people did key power calculations and amazing (or not so amazingly for epidemiologists) 500,000 was the minimum prospective cohort to have to impact common disease
Secondly the phenotyping has been done centrally and consistently, and some key imaging phenotypes have been done at scale. This is remarkable logistics, fund raising/arguments and delivery. *so* many things could have gone wrong which didn't.
Read 13 tweets
6 Feb
This weekend is a festival of sport in the UK - Premier League action (sadly - Arsenal lost); Start of Rugby's 6 nations; Superbowl - against a background of a COVID still whipping around us. Some thoughts from sport-heavy London:
Reminder: SARS-CoV-2 is an infectious virus which causes a nasty disease (COVID) in a subset of people (more likely if older; male; overweight) and sadly a proportion of people die who get the disease.
If we let the virus follow its natural course in populations our health care systems would be overwhelmed; far more people would die both due to the virus and other things and it would be near catastrophic for the function of modern society
Read 23 tweets
31 Jan
COVID thoughts on a cloudy late January day in London - longer evenings, and our house lockdown rhythm has settled somewhat.
Context: I am an expert in human genetics and computational biology; I know experts in infectious epidemiology, viral genomics, clinical trials and immunology. I have some COIs: I am a long established consultant to Oxford Nanopore and I am on the Ox/AZ vaccine trial.
Reminder: SARS-CoV-2 is infectious virus which causes a severe disease in a subset of people (older; more obese; male risk factors) often leading to death. If we let the virus go through the population both a large number of people would die and healthcare systems would melt
Read 21 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!